Apellis Pharmaceuticals Inc (APLS)
30.77
+3.02
(+10.88%)
USD |
NASDAQ |
Nov 22, 16:00
30.76
-0.01
(-0.03%)
After-Hours: 20:00
Apellis Pharmaceuticals Cash from Operations (Quarterly): 34.10M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 34.10M |
| June 30, 2024 | -8.339M |
| March 31, 2024 | -132.98M |
| December 31, 2023 | -97.88M |
| September 30, 2023 | -169.08M |
| June 30, 2023 | -150.16M |
| March 31, 2023 | -177.62M |
| December 31, 2022 | -140.74M |
| September 30, 2022 | -154.42M |
| June 30, 2022 | -107.02M |
| March 31, 2022 | -111.56M |
| December 31, 2021 | -112.50M |
| September 30, 2021 | -168.62M |
| June 30, 2021 | -128.69M |
| March 31, 2021 | -153.31M |
| December 31, 2020 | 141.98M |
| Date | Value |
|---|---|
| September 30, 2020 | -99.82M |
| June 30, 2020 | -94.29M |
| March 31, 2020 | -108.35M |
| December 31, 2019 | -82.07M |
| September 30, 2019 | -53.60M |
| June 30, 2019 | -39.91M |
| March 31, 2019 | -35.56M |
| December 31, 2018 | -44.48M |
| September 30, 2018 | -33.13M |
| June 30, 2018 | -30.69M |
| March 31, 2018 | -22.94M |
| December 31, 2017 | -15.53M |
| September 30, 2017 | -11.14M |
| June 30, 2017 | -11.50M |
| March 31, 2017 | -8.427M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-177.62M
Minimum
Mar 2023
141.98M
Maximum
Dec 2020
-101.07M
Average
-112.03M
Median
Cash from Operations (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 221.48M |
| Ionis Pharmaceuticals Inc | -114.99M |
| EyePoint Pharmaceuticals Inc | -39.03M |
| Cassava Sciences Inc | -18.30M |
| Macrogenics Inc | 60.16M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 2.542M |
| Free Cash Flow | -205.58M |
| Free Cash Flow Per Share (Quarterly) | 0.2745 |
| Free Cash Flow to Equity (Quarterly) | 39.06M |
| Free Cash Flow to Firm (Quarterly) | 43.84M |
| Free Cash Flow Yield | -5.43% |